Last reviewed · How we verify

NCT06564285

The Effects of a Novel Nutritional Product on Nutrient Gaps and Gut Health in Adults With Occasional Gastrointestinal Issues

Completed NA Last updated 4 May 2025
What this trial tests

NA trial testing AG1 - Nutritional Supplement in Gastrointestinal Microbiome in 24 participants. Completed in 1 February 2025.

Timeline
28 August 2024
Primary endpoint
1 February 2025
1 February 2025

Quick facts

Lead sponsorAthletic Greens International
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingtriple
Primary purposetreatment
Enrollment24
Start date28 August 2024
Primary completion1 February 2025
Estimated completion1 February 2025
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Athletic Greens International — full company profile →

Who can join

Adults 18 to 60, any sex, with Gastrointestinal Microbiome or Nutrition, Healthy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is a randomized, double-blind, placebo-controlled study of N=40 adult men and women with occasional GI issues. This study to assess the effect of a novel dietary supplement on the gut microbiome, nutrient gaps, and tolerability.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of AG1 - Nutritional Supplement

Trials testing the same drug.

Other recruiting trials for Gastrointestinal Microbiome

Currently open trials in the same condition.

Other Athletic Greens International trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06564285.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing